antibiotic

Drug Price Legislation Faces Challenges

[vc_row][vc_column][rev_slider_vc alias="drug-legistlation"][/vc_column][/vc_row][vc_row][vc_column width="1/2"][vc_column_text]In May we released an article about a proposed rule coming down from CMS regarding drug prices in advertising. In June we noted that drug companies were fighting this rule in court. This month we see the setbacks and challenges the Trump Administration continue to face in lowering drug prices for the everyday American. On July 8, federal courts ruled that the Department of Health and Human Services (HHS)...

Donna White
Share
executive order

Executive Order Reduces HHS Time for Transparency

[vc_row][vc_column][rev_slider_vc alias="executive-order"][/vc_column][/vc_row][vc_row][vc_column width="1/2"][vc_column_text]An executive order issued this week calls for the U.S. Department of Health and Human Services (HHS) to write the hospital requirements on price transparency in the next 60 days. This should mandate “standard charge information, including charges and information based on negotiated rates and for common or shoppable items.” But what are common or shoppable items? These are treatments and procedures widely available from hospitals and doctors. According...

Donna White
Share